MicroRNA-122-5p alleviates endometrial fibrosis via inhibiting the TGF-β/SMAD pathway in Asherman's syndrome
Reproductive BioMedicine Online · 2023-11 · 47 (5) · 103253
DOI: 10.1016/j.rbmo.2023.06.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2023-11. Verfasst von Sijia Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchu…. Hauptthemen laut MEDLINE: Gynatresia, Uterine Diseases, MicroRNAs. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
RESEARCH QUESTION: What is the effect of miR-122 on the progression and recovery of fibrosis in Asherman's syndrome? DESIGN: Endometrial tissue was collected from 21 patients, 11 with intrauterine adhesion (IUA) and 10 without IUA. Quantitative real-time polymerase chain reaction, immunofluorescence and Western blot were applied to observe the expression of mRNAs/miRNAs and protein, respectively. The endometrial physical injury was carried out in C57BL/6 mice to create an endometrial fibrosis model, with intrauterine injection of adenovirus to compare the antifibrosis and repair function of miR-122 on endometrium. The morphology of the uterus was observed using haematoxylin and eosin staining, and fibrosis markers were detected by immunohistochemistry. RESULTS: miR-122 expression was reduced in patients with IUAs, accompanied by fibrosis. MiR-122 overexpression reduced the degree of fibrosis in endometrial stromal cells. Further molecular analyses demonstrated that miR-122 inhibited fibrosis through the TGF-β/SMAD pathway by directly targeting the 3' untranslated region of SMAD family member 3, suppressing its expression. Notably, miR-122 promoted endometrial regeneration and recovery of pregnancy capacity in a mouse endometrial injury model. CONCLUSIONS: miR-122 is a critical regulator for repair of endometrial fibrosis and provided new insight for the clinical treatment of intrauterine adhesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchun East Road, Jianggan District, Hangzhou, 310016, China.; Key Laborato…
- Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchun East Road, Jianggan District, Hangzhou, 310016, China.; Department o…
- Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchun East Road, Jianggan District, Hangzhou, 310016, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chen, S., Ma, Y., Qiu, X., Liu, M., Zhang, P., Wei, C., Dai, Y., Ge, L., Zhu, H., Zhang, Y., Zhang, J., & Lin, X. (2023). MicroRNA-122-5p alleviates endometrial fibrosis via inhibiting the TGF-β/SMAD pathway in Asherman's syndrome. Reproductive BioMedicine Online, 47(5), 103253. https://doi.org/10.1016/j.rbmo.2023.06.008
Vancouver
Chen S, Ma Y, Qiu X, Liu M, Zhang P, Wei C, et al. MicroRNA-122-5p alleviates endometrial fibrosis via inhibiting the TGF-β/SMAD pathway in Asherman's syndrome. Reproductive BioMedicine Online. 2023;47(5):103253. doi:10.1016/j.rbmo.2023.06.008
BibTeX
@article{Chen2023,
author = {Chen, Sijia and Ma, Yana and Qiu, Xiaoxiao and Liu, Mengying and Zhang, Peipei and Wei, Cheng and Dai, Yongdong and Ge, Linyan and Zhu, Haiyan and Zhang, Yanling and Zhang, Jiaren and Lin, Xiaona},
title = {MicroRNA-122-5p alleviates endometrial fibrosis via inhibiting the TGF-β/SMAD pathway in Asherman's syndrome},
journal = {Reproductive BioMedicine Online},
year = {2023},
volume = {47},
number = {5},
pages = {103253},
doi = {10.1016/j.rbmo.2023.06.008}
}
EUVIMED